Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-02-24 @ 7:04 AM
Study NCT ID:
NCT02899793
Status:
COMPLETED
Last Update Posted:
2025-06-11
First Post:
2016-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Sponsor:
Organization: